Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhengchen Yu
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Wenzhou Medical University,
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0003-0192-0872
Observed ORCID:
0000-0003-0192-0872
OpenAlex ID:
A5032375275
Is Tailored Bismuth Quadruple Therapies (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial
2025
·
Zhengchen Yu
, Xiaochen Liu
, et al.
·
Helicobacter
·
12
PDF
Does vitamin D level associate with pregnancy outcomes in Chinese women undergoing in vitro fertilization/intracytoplasmic sperm injection‐embryo transfer? A retrospective cohort study
2022
·
Zhengchen Yu
, Yiqun Sun
, et al.
·
Journal of obstetrics and gynaecology research
·
9
PDF
BMI modifies the effect of pregnancy complications on risk of small- or large-for-gestational-age newborns
2024
·
Peng Wang
, Zhengchen Yu
, et al.
·
Pediatric Research
·
3
Histological Helicobacter pylori Density Might Not be Associated With the Severity of Neutrophilic Inflammatory Activity
2026
·
Guochun Lou
, Zhengchen Yu
, et al.
·
DEN Open
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial”
2025
·
Zhengchen Yu
, Wenjuan Shen
, et al.
·
Helicobacter
PDF
Show more works
View as search
Works count:
5
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type